Article ID Journal Published Year Pages File Type
6184141 Gynecologic Oncology 2015 28 Pages PDF
Abstract
This retrospective analysis supports that combination chemotherapy and bevacizumab prolongs PFS and OS compared with bevacizumab alone.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
Comparison of bevacizumab alone or with chemotherapy in recurrent ovarian cancer patients
Authors
, , , , , , , , , ,